Dimensional Fund Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,236,096
Closed -$48.6M 3552
2023
Q2
$48.6M Sell
1,236,096
-150,437
-11% -$5.31M 0.02% 1376
2023
Q1
$33.7M Sell
1,386,533
-47,742
-3% -$1.05M 0.01% 1619
2022
Q4
$30.7K Sell
1,434,275
-124,938
-8% -$2.67M 0.01% 1639
2022
Q3
$28M Buy
1,559,213
+252,924
+19% +$3.32M 0.01% 1630
2022
Q2
$12.6M Buy
1,306,289
+260,041
+25% +$3.26M ﹤0.01% 2101
2022
Q1
$17.6M Sell
1,046,248
-40,241
-4% -$595K 0.01% 2030
2021
Q4
$18.2M Sell
1,086,489
-11,600
-1% -$190K 0.01% 2036
2021
Q3
$17.8M Buy
1,098,089
+557,211
+103% +$6.06M 0.01% 2059
2021
Q2
$3.41M Buy
540,878
+269,640
+99% +$1.74M ﹤0.01% 2716
2021
Q1
$1.67M Sell
271,238
-9,783
-3% -$59.4K ﹤0.01% 2897
2020
Q4
$1.94M Sell
281,021
-5,100
-2% -$32.6K ﹤0.01% 2816
2020
Q3
$1.61M Buy
286,121
+24,400
+9% +$116K ﹤0.01% 2805
2020
Q2
$1.34M Sell
261,721
-63,386
-19% -$264K ﹤0.01% 2863
2020
Q1
$1.12M Buy
325,107
+63,246
+24% +$370K ﹤0.01% 2867
2019
Q4
$2.25M Buy
261,861
+17,601
+7% +$62.9K ﹤0.01% 2828
2019
Q3
$274K Hold
244,260
﹤0.01% 3241
2019
Q2
$318K Sell
244,260
-121,840
-33% -$167K ﹤0.01% 3260
2019
Q1
$516K Sell
366,100
-440,510
-55% -$616K ﹤0.01% 3161
2018
Q4
$968K Sell
806,610
-151,527
-16% -$294K ﹤0.01% 3021
2018
Q3
$2.26M Buy
958,137
+91,041
+10% +$227K ﹤0.01% 2900
2018
Q2
$2.37M Buy
867,096
+303,825
+54% +$838K ﹤0.01% 2845
2018
Q1
$1.54M Buy
563,271
+377,267
+203% +$1.09M ﹤0.01% 2912
2017
Q4
$580K Buy
+186,004
New +$523K ﹤0.01% 3075

Dimensional Fund Advisors's ISEE Position: Q3 2023 in Review

Dimensional Fund Advisors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 1,236,096 shares — an estimated $48.6M sold.

Dimensional Fund Advisors first reported a position in ISEE in Q4 2017 and held it in 23 quarters. The position peaked at $48.6M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Dimensional Fund Advisors reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 1,236,096 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $48.6M.
  • Dimensional Fund Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q4 2017 and held it in 23 quarters.
  • Dimensional Fund Advisors's IVERIC bio, Inc. Common Stock position peaked at $48.6M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Dimensional Fund Advisors's 13F filing for Q3 2023, filed 9 Nov 2023.